(Q85107660)
Statements
A phase I study of personalized peptide vaccination using 14 kinds of vaccine in combination with low-dose estramustine in HLA-A24-positive patients with castration-resistant prostate cancer (English)
Masanori Noguchi
Hirotsugu Uemura
Seiji Naito
Hideyuki Akaza
Akira Yamada
28 September 2010